<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://harvardscience.harvard.edu" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>all Michael Mourez stories</title>
 <link>http://harvardscience.harvard.edu/stories/person/1294</link>
 <description>Stories and external links referencing a person (RSS)</description>
 <language>en</language>
<item>
 <title>Anthrax toxin receptor discovered</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/anthrax-toxin-receptor-discovered</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;The first point of contact between anthrax toxin that invades the body and the cells that the toxin will eventually destroy is a protein, known as a &quot;docking&quot; protein or receptor. This docking protein was recently discovered by researchers at Harvard Medical School and the University of Wisconsin Medical School. Their discovery will, they hope, lead to a strategy for fighting anthax infection, even after symptoms have developed and treatment with antibiotics is no longer effective. The discovery was reported in Nature online on Oct. 23, 2001, and in the Nov. 8, 2001, print edition.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/anthrax-toxin-receptor-discovered&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:16:14 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3051 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>A strategy to neutralize anthrax toxin in the body</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/strategy-neutralize-anthrax-toxin-body</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A Harvard Medical School research team has developed a strategy to neutralize anthrax toxin in the body. So far they have tried the treatment in rats. Normally, rats die within hours after being injected with anthrax toxin. But when the toxin was followed minutes later with an injection of an inhibiting agent known as a polyvalent ligand -- itself completely innocuous -- the rats were protected from the toxin&#039;s effects. Asked if the polyvalent ligand can be tested in humans, research team leader R.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/strategy-neutralize-anthrax-toxin-body&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:16:12 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3050 at http://harvardscience.harvard.edu</guid>
</item>
</channel>
</rss>
